Utilize the data and tweets at hand to foresee if the closing price of $nvs will elevate or diminish at 2015-06-05. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2015-05-21,-0.3,0.3,-0.5,1.2,1.2,-0.8,-1.3,-1.6,-1.6,-1.5,-1.5
2015-05-22,0.1,0.7,-0.0,-0.9,-0.9,0.1,-0.3,-0.7,-0.7,-0.5,-0.6
2015-05-26,1.3,1.3,-0.0,-2.0,-2.0,1.7,1.6,1.2,1.2,1.4,1.4
2015-05-27,-0.7,0.2,-0.8,1.7,1.7,-0.0,0.0,-0.4,-0.5,-0.3,-0.3
2015-05-28,-0.4,0.1,-0.7,0.7,0.7,-0.6,-0.5,-0.9,-1.1,-0.9,-1.0
2015-05-29,1.3,1.8,-0.5,-1.5,-1.5,0.5,0.9,0.6,0.4,0.4,0.5
2015-06-01,0.5,0.6,-0.5,0.5,0.5,-0.2,0.3,0.1,-0.1,-0.1,-0.0
2015-06-02,0.1,0.4,-0.2,-0.3,-0.3,0.4,0.5,0.5,0.2,0.2,0.3
2015-06-03,0.0,0.7,-0.1,0.7,0.7,-0.3,-0.2,-0.2,-0.5,-0.6,-0.4
2015-06-04,0.1,0.8,-0.4,-0.6,-0.6,0.1,0.3,0.5,0.2,0.0,0.2

2015-05-23: AT_USER AT_USER $nvs cosentyx (secukinumab) label has no mention of any this type of signal: |rt AT_USER $amgn drops brodalumab, il-17 partnership; solidifying $nvs front runner position 4 their il-17
2015-05-30: lnkd linkedin corp. ask size$lnkd $pbr $dis $nvs #lnkd #stocks #stock
2015-06-01: rt AT_USER can the nosebleed-high prices of cancer drugs ever be contained?  #asco15 $bmy $mrk $nvs|correction:pi study of medi4736 wdabrafenib +/- trametinib in adv melanoma 69% orr w/triple therapy 
Answer:
Utilize the data and tweets at hand to foresee if the closing price of $nvs will elevate or diminish at 2015-06-05. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2015-05-21,-0.3,0.3,-0.5,1.2,1.2,-0.8,-1.3,-1.6,-1.6,-1.5,-1.5
2015-05-22,0.1,0.7,-0.0,-0.9,-0.9,0.1,-0.3,-0.7,-0.7,-0.5,-0.6
2015-05-26,1.3,1.3,-0.0,-2.0,-2.0,1.7,1.6,1.2,1.2,1.4,1.4
2015-05-27,-0.7,0.2,-0.8,1.7,1.7,-0.0,0.0,-0.4,-0.5,-0.3,-0.3
2015-05-28,-0.4,0.1,-0.7,0.7,0.7,-0.6,-0.5,-0.9,-1.1,-0.9,-1.0
2015-05-29,1.3,1.8,-0.5,-1.5,-1.5,0.5,0.9,0.6,0.4,0.4,0.5
2015-06-01,0.5,0.6,-0.5,0.5,0.5,-0.2,0.3,0.1,-0.1,-0.1,-0.0
2015-06-02,0.1,0.4,-0.2,-0.3,-0.3,0.4,0.5,0.5,0.2,0.2,0.3
2015-06-03,0.0,0.7,-0.1,0.7,0.7,-0.3,-0.2,-0.2,-0.5,-0.6,-0.4
2015-06-04,0.1,0.8,-0.4,-0.6,-0.6,0.1,0.3,0.5,0.2,0.0,0.2

2015-05-23: AT_USER AT_USER $nvs cosentyx (secukinumab) label has no mention of any this type of signal: |rt AT_USER $amgn drops brodalumab, il-17 partnership; solidifying $nvs front runner position 4 their il-17
2015-05-30: lnkd linkedin corp. ask size$lnkd $pbr $dis $nvs #lnkd #stocks #stock
2015-06-01: rt AT_USER can the nosebleed-high prices of cancer drugs ever be contained?  #asco15 $bmy $mrk $nvs|correction:pi study of medi4736 wdabrafenib +/- trametinib in adv melanoma 69% orr w/triple therapy 
Answer:+Fall